Gregory M. Glenn
2018
In 2018, Gregory M. Glenn earned a total compensation of $1.7M as President, Research and Development at Novavax, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $79,142 |
|---|---|
| Option Awards | $1,131,189 |
| Salary | $460,125 |
| Other | $11,000 |
| Total | $1,681,456 |
Glenn received $1.1M in option awards, accounting for 67% of the total pay in 2018.
Glenn also received $79.1K in non-equity incentive plan, $460.1K in salary and $11K in other compensation.
Rankings
In 2018, Gregory M. Glenn's compensation ranked 6,604th out of 14,244 executives tracked by ExecPay. In other words, Glenn earned more than 53.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,604 out of 14,244 | 54th |
Division Manufacturing | 2,528 out of 5,762 | 56th |
Major group Chemicals And Allied Products | 947 out of 2,125 | 55th |
Industry group Drugs | 794 out of 1,814 | 56th |
Industry Biological Products, Except Diagnostic Substances | 151 out of 339 | 56th |
Pay ratio
| Gregory M. Glenn's Pay | $1,681,456 |
|---|---|
| Median Employee's Pay | $123,614 |
| Pay Ratio | 14to 1 |
In 2018, the annual total compensation of Gregory M. Glenn was $1,681,456.
The annual total compensation of the median employee at Novavax was $123,614.
The ratio of Gregory M. Glenn's pay to the pay of median employee was therefore 14 to one.
Source: SEC filing on May 16, 2019.
Glenn's colleagues
We found three more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2018.